Patents Assigned to Sigma-Tau Rare Diseases, S.A.
  • Adenosine deaminase anticancer therapy
    Patent number: 8741283
    Abstract: What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: June 3, 2014
    Assignee: Sigma-Tau Rare Diseases, S.A.
    Inventors: David R. Filpula, Puja Sapra